We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current IBT market cap is 257.88M. The company's latest EPS is GBP 0.1886 and P/E is 37.86.
| Year End August 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | -13.27M | 57.03M | 32.1M | -13.58M | 12.06M |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | -17.54M | 53.42M | 27.89M | -22.47M | 6.81M |
| Year End August 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 240.86M | 302.71M | 347.84M | 326.92M | 304.87M |
| Total Liabilities | 1.28M | 18.81M | 24.06M | 42.03M | 34.55M |
| Total Equity | 239.58M | 283.9M | 323.78M | 284.89M | 270.32M |
| Year End August 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | 6.47M | -9.55M | -14.53M | 1.12M | 27.3M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | -5.35M | -9.11M | 11.99M | -16.41M | -21.39M |
| Market Cap | 257.88M |
| Price to Earnings Ratio | 37.86 |
| Price to Sales Ratio | 21.38 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0.95 |
| Dividend Yield | 4.21% |
| Shares Outstanding | 36.12M |
| Average Volume (1 week) | 80.52k |
| Average Volume (1 Month) | 72.4k |
| 52 Week Change | 7.53% |
| 52 Week High | 734.00 |
| 52 Week Low | 598.00 |
| Spread (Intraday) | 4 (0.56%) |
| Company Name | International Biotechnology Trust Plc |
| Address |
6th floor, 65 gresham street london EC2V 7NQ |
| Website | https://www.ibtplc.com |
| Industry | trusts (6730) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
